Searching journal content for articles similar to Prazeres et al. 23 (12): X1.

Displaying results 1-10 of 1800
For checked items
  1. ...’s Hospital & University of British Columbia, Vancouver, British Columbia, Canada Abstract The RET receptor tyrosine kinase mediates cell proliferation, survival and migration in embryogenesis and is implicated in the transformation and tumour progression in multiple cancers. RET is frequently mutated...
  2. ...known as PTTG1IP or c21orf3) as a proto-oncogene based on the transformation potential of PBF in vitro and its ability to induce tumours in xenograft models (Stratford et al. 2005). We and others have demonstrated that PBF is overexpressed in pituitary, thyroid, breast and colorectal tumours...
  3. ...ite1,2,3 2Servic¸o de Endocrinologia, Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., Rua Prof. Lima Basto, 1099-023 Lisboa, Portugal to M M Moura min-saude.pt prognosis, and cases with other RET mutations, which have the most indolent course of the Key Words " RAS proto-oncogene...
  4. ..., and Glu511Lys of undetermined pathogenic significance,Abstract(sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886Trp Hugo Prazeres1,2,4, Joana P Couto1, Fernando Rodrigues3, Joa˜o Vinagre1, Joana Torres1, Vitor Trovisco1, Teresa C Martins2, Manuel Sobrinho-Simo˜es1,4 and Paula...
  5. ..., Dieguez C, Japon MA & Alvarez CV 2012 Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors. Journal of Clinical Endocrinology and Metabolism 97 E80–E87. (doi:10.1210/jc.2011-2187) Gaston-Massuet C, Andoniadou...
  6. ...in all inherited cases of MTC, activating point mutations of 26 the RET proto-oncogene are found. RET encodes for a receptor tyrosine kinase protein 27 endowed with transforming potential on thyroid parafollicular cells. As in other cancer 28 types, microenvironmental factors play a critical role in MTC...
  7. ...-Yarmand R, Sinha KM, Gururaj AE, Ahmed Z, Rizvi YQ, Huang SC, Ladbury JE, Bogler O, Williams MD, Cote GJ, et al. 2015 A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis. Journal of Biological Chemistry 290 11749–11761. (doi:10.1074/ jbc...
  8. ...inheritance of a gain-of-function mutation in the RET proto-oncogene on chromosome 10 (Mulligan & Ponder 1995, Santoro et al. 1995) and is further subclassified into three syndromes based on clinical phenotype: MEN2A (medullary thyroid cancer (MTC), pheochromocytoma, primary parathyroid hyperplasia); MEN2B...
  9. ...SA Jr 1993 Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Human Molecular Genetics 2 851–856. (doi:10.1093/hmg/2.7.851) Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, van Amstel HK, Lips CJ, Nishisho I, Takai SI, et al. 1996 The relationship between specific...
  10. .... Endocrine Related Cancer 18 603–612. (doi:10.1530/ERC-11-0117) Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GF, Jackson CE, Tunnacliffe A, et al. 1994 Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B...
For checked items